New diabetes clinical trial: Evaluation of the Efficacy of Permanent Course Combined Therapy with CYTOFLAVIN® Intravenous Solution and CYTOFLAVIN Tablets, At 2-3 Stages of Rehabilitation of Patients with Post Intensive Care Syndrome
Published on: December 15, 2024 at 11:00PM
Conditions: Ischemic Stroke
Sponsors: POLYSAN Scientific & Technological Pharmaceutical Company
Recruiting
https://ift.tt/JDPOYVL
Conditions: Ischemic Stroke
Sponsors: POLYSAN Scientific & Technological Pharmaceutical Company
Recruiting
https://ift.tt/JDPOYVL
Comments
Post a Comment